209 related articles for article (PubMed ID: 28049456)
1. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.
Lim AM; Rischin D; Fisher R; Cao H; Kwok K; Truong D; McArthur GA; Young RJ; Giaccia A; Peters L; Le QT
Clin Cancer Res; 2012 Jan; 18(1):301-7. PubMed ID: 22096023
[TBL] [Abstract][Full Text] [Related]
3. Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.
Snitcovsky I; Leitão GM; Pasini FS; Brunialti KC; Mangone FR; Maistro S; de Castro G; Villar RC; Federico MH
Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):807-11. PubMed ID: 19687403
[TBL] [Abstract][Full Text] [Related]
4. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
[TBL] [Abstract][Full Text] [Related]
5. Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer.
Ostheimer C; Bache M; Güttler A; Reese T; Vordermark D
BMC Cancer; 2014 Nov; 14():858. PubMed ID: 25416631
[TBL] [Abstract][Full Text] [Related]
6. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
Le QT; Sutphin PD; Raychaudhuri S; Yu SC; Terris DJ; Lin HS; Lum B; Pinto HA; Koong AC; Giaccia AJ
Clin Cancer Res; 2003 Jan; 9(1):59-67. PubMed ID: 12538452
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of osteopontin in patients treated with primary radiotherapy for head and neck cancer.
Etiz D; Ataizi FC; Bayman E; Akcay M; Acikalin MF; Colak E; Ciftci E
Asian Pac J Cancer Prev; 2013; 14(9):5175-8. PubMed ID: 24175796
[TBL] [Abstract][Full Text] [Related]
9. Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma.
Hollevoet K; Nackaerts K; Gosselin R; De Wever W; Bosquée L; De Vuyst P; Germonpré P; Kellen E; Legrand C; Kishi Y; Delanghe JR; van Meerbeeck JP
J Thorac Oncol; 2011 Nov; 6(11):1930-7. PubMed ID: 21841505
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.
Zhang H; Ye QH; Ren N; Zhao L; Wang YF; Wu X; Sun HC; Wang L; Zhang BH; Liu YK; Tang ZY; Qin LX
J Cancer Res Clin Oncol; 2006 Nov; 132(11):709-17. PubMed ID: 16786357
[TBL] [Abstract][Full Text] [Related]
11. Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.
Vordermark D; Said HM; Katzer A; Kuhnt T; Hänsgen G; Dunst J; Flentje M; Bache M
BMC Cancer; 2006 Aug; 6():207. PubMed ID: 16911785
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer.
Maleš J; Mihalj H; Šestak A; Kralik K; Smolić M
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33670031
[No Abstract] [Full Text] [Related]
14. Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma.
Zhou C; Zhou HJ; Zhang XF; Lou LL; Ye QH; Zheng Y; Wang J; Zhu HT; Dong QZ; Jia HL; Zhu WW; Guo L; Zhao Y; Gao DM; Qin LX
Ann Surg Oncol; 2013 Mar; 20(3):929-37. PubMed ID: 23203407
[TBL] [Abstract][Full Text] [Related]
15. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
[TBL] [Abstract][Full Text] [Related]
16. Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer.
Suwinski R; Giglok M; Galwas-Kliber K; Idasiak A; Jochymek B; Deja R; Maslyk B; Mrochem-Kwarciak J; Butkiewicz D
BMC Cancer; 2019 May; 19(1):427. PubMed ID: 31068179
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of elevated osteopontin levels in head and neck cancer patients.
Eto M; Kodama S; Nomi N; Uemura N; Suzuki M
Auris Nasus Larynx; 2007 Sep; 34(3):343-6. PubMed ID: 17254728
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of osteopontin expression and laryngeal squamous cell carcinoma infiltration and metastasis].
Zhao Hongchun ; Wang Yanfei ; Zheng Tihua ; Che Juan ; Cao Ruijuan ; Wang Xia
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(17):1530-3. PubMed ID: 26647537
[TBL] [Abstract][Full Text] [Related]
19. Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer.
Ng L; Wan TM; Lam CS; Chow AK; Wong SK; Man JH; Li HS; Cheng NS; Pak RC; Cheung AH; Yau TC; Lo OS; Foo DC; Poon JT; Poon RT; Pang RW; Law WL
PLoS One; 2015; 10(5):e0126219. PubMed ID: 25961724
[TBL] [Abstract][Full Text] [Related]
20. Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.
Blasberg JD; Pass HI; Goparaju CM; Flores RM; Lee S; Donington JS
J Clin Oncol; 2010 Feb; 28(6):936-41. PubMed ID: 20085934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
